333D Ltd reports continued revenue growth in digital asset management and unveils a pioneering blockchain solution for MRI data storage, reinforcing its foothold in digital healthcare.
- Sixth consecutive quarter of revenue growth with 3.92% increase
- Net operating cash outflow of $99,180 for the quarter
- Bitcoin treasury valued at AUD 257,363
- Successful blockchain integration for full body MRI scan data
- Payments to related parties total $113,351
Steady Growth in Digital Asset Management
333D Ltd (ASX, T3D) has reported its quarterly cash flow and activities for the period ending 31 December 2025, marking its sixth consecutive quarter of growth in digital asset management revenues. The company generated $330,917 in cash receipts from customers, reflecting a 3.92% increase over the previous quarter. This steady climb underscores the success of 333D’s strategic pivot towards servicing the healthcare sector with bespoke digital asset management solutions.
Financial Position and Expenditure
Despite the revenue growth, the company recorded a net operating cash outflow of $99,180 for the quarter, a reversal from the previous quarter’s cash inflow of $160,742. Total expenditure amounted to approximately $430,097, covering service and operating costs, staff salaries, and administration expenses. Notably, payments to related parties during the quarter reached $113,351, including consulting fees and reimbursements to entities connected with key directors.
Bitcoin Treasury and Cash Reserves
333D maintains a Bitcoin holding valued at AUD 257,363, complementing its cash balance of $736,328. Together, these assets provide the company with a total cash and cash equivalents position just shy of AUD 1 million. This diversified treasury approach reflects a cautious yet opportunistic stance amid evolving digital asset markets.
Innovative Blockchain Application in Healthcare
Highlighting its technological edge, 333D announced the successful recording of vital data from full body MRI scans onto the blockchain. This innovation enables decentralised storage and grants patients secure, auditable ownership of their medical data. The company is actively pursuing national expansion of this blockchain-enabled digital asset platform through partnerships with preventative healthcare providers, signaling a promising new frontier in patient data management.
Looking Ahead
While the quarter did not involve any new capital raising or formal use of funds statements, 333D’s focus remains on scaling its blockchain healthcare solution and sustaining revenue growth. The company’s ability to convert technological innovation into commercial traction will be critical as it navigates competitive pressures and evolving regulatory landscapes.
Bottom Line?
333D’s blockchain breakthrough in MRI data storage could redefine patient data control, but execution risks remain as it scales.
Questions in the middle?
- How rapidly will 333D’s blockchain MRI data solution gain adoption across the healthcare sector?
- What governance measures are in place to manage related party transactions transparently?
- Can the company sustain revenue growth while managing operating cash outflows?